The ongoing coronavirus disease 2019 (COVID-19) pandemic has affected millions
worldwide and has been found to cause severe disease in patients with underlying …

COVID-19 and malignancy can affect the susceptibility of one another. Clinically recovered
COVID-19 individuals display immune abnormalities that persist several months after …

As of September 19, 2020, about 30 million people have been infected with the novel
corona virus disease 2019 (COVID-19) globally, and the numbers are increasing at an …

Background: SARS-CoV-2, the cause of the worldwide COVID-19 pandemic, utilizes the
mechanism of binding to ACE2 (a crucial component of the renin-angiotensin system [RAS]) …

Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) continues to be a
worldwide healthcare problem. While our knowledge of the interaction of cancer and its …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown diverse life-
threatening effects, most of which are considered short-term. In addition to its short-term …

Previous studies suggested that patients with comorbidities including cancer had a higher
risk of mortality or developing more severe forms of COVID-19. The interaction of cancer and …

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
marked the beginning of a new pandemic named coronavirus disease 2019 (COVID-19) …

Neuropilin-1 (NRP1) is a recently identified glycoprotein that is an important host factor for
SARS-CoV-2 infection. On the other hand, angiotensin-converting enzyme-2 (ACE2) acts as …

The COVID-19 pandemic has engulfed the entire world and has claimed more than 3 million
lives worldwide. This viral disease is caused by severe acute respiratory syndrome …